Bodytrak: early-detection of infectious diseases in industrial and front-line workers

对于在温暖气候中工作和/或穿着防护服(PPE)的产业工人来说，热应激是一个主要问题。中暑造成的经济损失平均为每人每年504 GB。在Inova，我们开发了Bodytrak(R)，这是一种创新的远程监测系统，用于实时获取生命体征。通过一个小型的入耳式设备，核心体温和心率被持续测量并传输到Bodytrak云平台，在实时仪表板上显示生命体征/警报。世界卫生组织于2020年3月宣布Covid-19大流行。对生产工厂、炼油厂、物流和建筑公司等工业组织的影响是，由于经济放缓，收入减少，但也由于新冠肺炎事件以及要求社会距离需要更少的现场工人，导致生产率产出减少。雇主必须在员工福利和减少经济影响之间取得平衡，并一直在投资于声称可以及早检测新冠肺炎的技术，例如热像仪，但MHRA报告称，这些产品不可靠，因为它们测量的是皮温，而不是CBT。此外，单靠温度并不足以提供可靠的评估。这项建议旨在扩展Bodytrak入耳式解决方案的功能，以测量额外的生命体征来自动检测新冠肺炎(和其他传染病)，特别是对于经常佩戴该设备的工业和一线工人。目前全球可定位市场为83.5亿GB(英国)(2019年)，增长率为10%-42%，可服务市场为1.35亿GB。

Heat stress is a major issue for industrial workers operating in warm climates and/or wearing protective clothing (PPE). Economic costs due to heat illness are £504 on average per worker annually. At Inova, we developed Bodytrak(r), an innovative remote monitoring system used to acquire vital signs in real-time. From a small in-ear device, core body temperature and heart rate are continuously measured and transmitted to the Bodytrak cloud platform to display vital signs/alerts on a real-time dashboard.Covid-19 was declared a pandemic in March 2020 by WHO. The impact to industrial organisations, such as production plants, refineries, logistics and constructions firms has been a reduction in revenue due to economic slowdown, but also a reduction in productivity output due to cases of Covid-19 and the requirement for social distancing requiring fewer workers on site. Employers have to balance worker welfare with reducing economic impact and have been investing in technology which claims to provide early detection of Covid-19, e.g. thermal cameras, but MHRA reported that these products are not reliable since they measure skin temperature not CBT. Further, temperature alone is not adequate in providing a reliable assessment.This proposal seeks to expand the functionality of the Bodytrak in-ear solution to measure additional vital signs to automatically detect Covid-19 (and other infectious diseases), particularly for industrial and front-line workers who would wear the device routinely. The addressable market currently represents £8.35Bn globally (£476m UK) (2019), with growth rate 10-42%, and serviceable market £135m.